CEMIP as a potential biomarker and therapeutic target for breast cancer patients

Purpose: We aimed to evaluate whether CEMIP plays any role in the survival outcome of breast cancer (BC) patients, as well as to explore the regulatory mechanism of CEMIP in BC. Methods: We evaluated the expression and prognostic effect of CEMIP in BC patients using the Oncomine, GEPIA, UALCAN, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jinqi, Zhu, Xudong, Qiao, Xinbo, Wang, Yulun, Bu, Jiawen, Zhang, Xiaoying, Ma, Qingtian, Liang, Lu, Sun, Lisha, Liu, Caigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964326/
https://www.ncbi.nlm.nih.gov/pubmed/35370456
http://dx.doi.org/10.7150/ijms.58067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964326/
https://www.ncbi.nlm.nih.gov/pubmed/35370456
http://dx.doi.org/10.7150/ijms.58067

Ejemplares similares